These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 37710283)

  • 1. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
    Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
    Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of commercial kits for purification of circulating free DNA.
    Diefenbach RJ; Lee JH; Kefford RF; Rizos H
    Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance evaluation of kits for bisulfite-conversion of DNA from tissues, cell lines, FFPE tissues, aspirates, lavages, effusions, plasma, serum, and urine.
    Holmes EE; Jung M; Meller S; Leisse A; Sailer V; Zech J; Mengdehl M; Garbe LA; Uhl B; Kristiansen G; Dietrich D
    PLoS One; 2014; 9(4):e93933. PubMed ID: 24699908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA.
    Worm Ørntoft MB; Jensen SØ; Hansen TB; Bramsen JB; Andersen CL
    Epigenetics; 2017 Aug; 12(8):626-636. PubMed ID: 28557629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
    J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
    Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
    Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisulfite-Converted DNA Quantity Evaluation: A Multiplex Quantitative Real-Time PCR System for Evaluation of Bisulfite Conversion.
    Hong SR; Shin KJ
    Front Genet; 2021; 12():618955. PubMed ID: 33719336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance comparison of commercial kits for isolating and detecting circulating tumor DNA.
    Wang M; Huang X; Li X; Guo Q; Xu W; Zhao M; Wang X; Wang L; Lou J
    Scand J Clin Lab Invest; 2021 Jul; 81(4):276-281. PubMed ID: 33999736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing.
    Leontiou CA; Hadjidaniel MD; Mina P; Antoniou P; Ioannides M; Patsalis PC
    PLoS One; 2015; 10(8):e0135058. PubMed ID: 26247357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.
    Pérez-Barrios C; Nieto-Alcolado I; Torrente M; Jiménez-Sánchez C; Calvo V; Gutierrez-Sanz L; Palka M; Donoso-Navarro E; Provencio M; Romero A
    Transl Lung Cancer Res; 2016 Dec; 5(6):665-672. PubMed ID: 28149760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A blood test measuring DNA methylation of BCAT1 and IKZF1 for detection of lung adenocarcinoma.
    Mohamed FR; Rose A; Sheehan-Hennessy L; Pedersen SK; Cornthwaite K; Laven-Law G; Young GP; Symonds EL; Winter JM
    Cancer Treat Res Commun; 2024; 40():100838. PubMed ID: 39154541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.
    Terp SK; Pedersen IS; Stoico MP
    J Mol Diagn; 2024 Apr; 26(4):310-319. PubMed ID: 38336350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA.
    Janku F; Huang HJ; Pereira DY; Kobayashi M; Chiu CH; Call SG; Woodbury KT; Chao F; Marshak DR; Chiu RYT
    Sci Rep; 2021 Oct; 11(1):19653. PubMed ID: 34608196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
    Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
    Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
    Nesic M; Bødker JS; Terp SK; Dybkær K
    Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.
    Lee EY; Lee EJ; Yoon H; Lee DH; Kim KH
    Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32325682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating cell-free DNA from plasma undergoes less fragmentation during bisulfite treatment than genomic DNA due to low molecular weight.
    Werner B; Yuwono NL; Henry C; Gunther K; Rapkins RW; Ford CE; Warton K
    PLoS One; 2019; 14(10):e0224338. PubMed ID: 31652288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
    van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
    Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients.
    Leest PV; Boonstra PA; Elst AT; Kempen LCV; Tibbesma M; Koopmans J; Miedema A; Tamminga M; Groen HJM; Reyners AKL; Schuuring E
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.